Effects of sulindac sulfide on proliferation and apoptosis of human breast cancer cell

Sui,He‑Huan; Zhou,Yun‑Jiang; Wang,Hu; Li,Li; Cao,Min; Huang,Jia‑Jun

doi:10.3892/ol.2018.8331

Effects of sulindac sulfide on proliferation and apoptosis of human breast cancer cell

Authors:
- He‑Huan Sui
- Yun‑Jiang Zhou
- Hu Wang
- Li Li
- Min Cao
- Jia‑Jun Huang
View Affiliations

Affiliations: Department of Pharmacology, Chongqing Medical University, Chongqing 400016, P.R. China
Published online on: March 23, 2018 https://doi.org/10.3892/ol.2018.8331
Pages: 7981-7986

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to observe the effects of sulindac sulfide on the proliferation and apoptosis of human breast cancer cells MCF‑7, and to explore the potential underlying molecular mechanism. The inhibitory ratio was detected using a cell counting kit‑8 assay. The changes in cell cycle distribution were assessed using flow cytometry (FCM). Furthermore, the changes in cell apoptosis rates were detected by Hoechst 33258 staining and FCM coupled with Annexin V‑FITC/propidium iodide (PI) staining. In addition, the protein expression was detected using western blotting. Sulindac sulfide was able to inhibit the proliferation of breast cancer in a dose‑ and time‑dependent manner. In addition, sulindac sulfide altered the cell cycle of breast cancer cells. The results of Hoechst 33258 staining and FCM coupled with Annexin V‑FITC/PI staining demonstrated that sulindac sulfide could significantly induce the apoptosis of MCF‑7 cells in a dose‑dependent, and time‑dependent manner. The western blot analysis demonstrated the protein expression of Bcl‑2 was downregulated, and Bax and cleaved caspase‑3 were upregulated. The results of the present study suggest that sulindac sulfide can inhibit the proliferation and induce the apoptosis of MCF‑7 cells.

View Figures

View References

1	Span PN, Pollakis G, Paxton WA, Sweep FC, Foekens JA, Martens JW, Sieuwerts AM and van Laarhoven HW: Improved metastasis-free survival in nonadjuvantly treated postmenopausal breast cancer patients with chemokine receptor 5 del32 frameshift mutations. Int J Cancer. 136:91–97. 2015. View Article : Google Scholar : PubMed/NCBI
2	Fu J, Xu X, Kang L, Zhou L, Wang S, Lu J, Cheng L, Fan Z, Yuan B, Tian P, et al: miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2. Biochem Biophys Res Commun. 445:314–319. 2014. View Article : Google Scholar : PubMed/NCBI
3	Diller M, Schüler S, Buchholz S, Lattrich C, Treeck O and Ortmann O: Effects of estriol on growth, gene expression and estrogen response element activation in human breast cancer cell lines. Maturitas. 77:336–343. 2014. View Article : Google Scholar : PubMed/NCBI
4	Lenik J: Preparation and characterization of a sulindac sensor based on PVC/TOA-SUL membrane. Mater Sci Eng C Mater Biol Appl. 37:383–389. 2014. View Article : Google Scholar : PubMed/NCBI
5	Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR and Offerhaus GJ: Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med. 328:1313–1316. 1993. View Article : Google Scholar : PubMed/NCBI
6	Beazer-Barclay Y, Levy DB, Moser AR, Dove WF, Hamilton SR, Vogelstein B and Kinzler KW: Sulindac suppresses tumorigenesis in the Min mouse. Carcinogenesis. 17:1757–1760. 1996. View Article : Google Scholar : PubMed/NCBI
7	Mahmoud NN, Boolbol SK, Dannenberg AJ, Mestre JR, Bilinski RT, Martucci C, Newmark HL, Chadburn A and Bertagnolli MM: The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis. Carcinogenesis. 19:87–91. 1998. View Article : Google Scholar : PubMed/NCBI
8	Piazza GA, Alberts DS, Hixson LJ, Paranka NS, Li H, Finn T, Bogert C, Guillen JM, Brendel K, Gross PH, et al: Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res. 57:2909–2915. 1997.PubMed/NCBI
9	Thompson HJ, Jiang C, Lu J, Mehta RG, Piazza GA, Paranka NS, Pamukcu R and Ahnen DJ: Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Cancer Res. 57:267–271. 1997.PubMed/NCBI
10	Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, Aravin A, Brownstein MJ, Tuschl T and Margalit H: Clustering and conservation patterns of human microRNAs. Nucleic Acids Res. 33:2697–2706. 2005. View Article : Google Scholar : PubMed/NCBI
11	Lee YS, Choi D, Kim NY, Yang S, Jung E, Hong M, Yang D, Lenz HJ and Hong YK: CXCR2 inhibition enhances sulindac-mediated suppression of colon cancer development. Int J Cancer. 135:232–237. 2014. View Article : Google Scholar : PubMed/NCBI
12	Verma R, Brahmankar M, Kushwah L and Suresh B: Evaluating the inhibitory potential of sulindac against the bleomycin-induced pulmonary fibrosis in wistar rats. Environ Toxicol Pharmacol. 36:769–778. 2013. View Article : Google Scholar : PubMed/NCBI
13	Liggett JL, Min KW, Smolensky D and Baek SJ: A novel COX-independent mechanism of sulindac sulfide involves cleavage of epithelial cell adhesion molecule protein. Exp Cell Res. 326:1–9. 2014. View Article : Google Scholar : PubMed/NCBI
14	Huang WW, Ko SW, Tsai HY, Chung JG, Chiang JH, Chen KT, Chen YC, Chen HY, Chen YF and Yang JS: Cantharidin induces G2/M phase arrest and apoptosis in human colorectal cancer cells through inhibition of CDK1 activity and caspase-dependent signaling pathways. Int J Oncol. 38:1067–1073. 2011.PubMed/NCBI
15	Zhang YT, Ouyang DY, Xu LH, Ji Y, Zha Q, Cai J and He X: Cucurbitacin B induces rapid depletion of the G-actin pool through reactive oxygen species-dependent actin aggregation in melanoma cells. Acta Biochim Biophys Sin (Shanghai). 43:556–567. 2011. View Article : Google Scholar : PubMed/NCBI
16	Chen Q, Ouyang DY, Geng M, Xu LH, Zhang YT, Wang FP and He XH: Valproic acid exhibits biphasic effects on apoptotic cell death of activated lymphocytes through differential modulation of multiple signaling pathways. J Immunotoxicol. 8:210–218. 2011. View Article : Google Scholar : PubMed/NCBI
17	Greening DW, Ji H, Kapp EA and Simpson RJ: Sulindac modulates secreted protein expression from LIM1215 colon carcinoma cells prior to apoptosis. Biochim Biophy Acta. 1834:2293–2307. 2013. View Article : Google Scholar
18	Corbex M, Bouzbid S and Boffetta P: Features of breast cancer in developing countries, examples from North-Africa. Eur J Cancer. 50:1808–1818. 2014. View Article : Google Scholar : PubMed/NCBI
19	Li H, Yang AL, Chung YT, Zhang W, Liao J and Yang GY: Sulindac inhibits pancreatic carcinogenesis in LSL-Kras G12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing aldo-keto reductase family 1B10 (AKR1B10). Carcinogenesis. 34:2090–2098. 2013. View Article : Google Scholar : PubMed/NCBI
20	Sinicrope FA and Penington RC: Sulindac sulfide-induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2. Mol Cancer Ther. 4:1475–1483. 2005. View Article : Google Scholar : PubMed/NCBI
21	Kim YS, Seol CH, Jung JW, Oh SJ, Hwang KE, Kim HJ, Jeong ET and Kim HR: Synergistic effect of sulindac and simvastatin on apoptosis in lung cancer A549 cells through AKT-dependent downregulation of survivin. Cancer Res Treat. 47:90–100. 2015. View Article : Google Scholar : PubMed/NCBI
22	Fink SP, Dawson DM, Zhang Y, Kresak A, Lawrence EG, Yang P, Chen Y, Barnholtz-Sloan JS, Willis JE, Kopelovich L and Markowitz SD: Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemo-prevention with NSAIDs. Carcinogenesis. 36:291–298. 2015. View Article : Google Scholar : PubMed/NCBI
23	Katoumas KM, Nikitakis N, Perrea D, Dontas I and Sklavounou A: In vivo antineoplastic effects of the NSAID sulindac in an oral carcinogenesis model. Cancer Prev Res (Phila). 8:642–649. 2015. View Article : Google Scholar : PubMed/NCBI
24	Smalley W, Ray WA, Daugherty J and Griffin MR: Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: A population-based study. Arch Intern Med. 15:161–166. 1999. View Article : Google Scholar